Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 99 EP140 | DOI: 10.1530/endoabs.99.EP140

1University Hospital Center Zagreb, Department of endocrinology, Zagreb, Croatia; 2School of Medicine, University of Zagreb, Zagreb, Croatia


Background: Systematic or randomised studies on the natural course of non-functioning pituitary macroadenomas after surgery (NFPA) are lacking.

Objectives: This study aimed to evaluate the long-term outcomes of residual NFPA following pituitary surgery.

Methods: In this retrospective study, we included 130 patients with NPFA who underwent pituitary surgery between 2005 and 2018 at University Hospital Centre Zagreb. The median age of participants was 57 (18-78) years, and 65.4% were male. Data on demographics, surgical outcomes, histology, imaging, and management were collected. The median follow-up time was 90.5 (36-223) months after surgery. Patients with less than three years of follow-up were excluded from the study.

Results: The median adenoma size was 29.2 (10-55) mm, and in 58 (44.6%) cases, infiltration into the cavernous sinus was observed. In the group of patients who had complete tumour resection (n=45), ten (22.2%) experienced adenoma recurrence after a median follow-up period of 73.5 (22-216) months. They showed no differences in age, gender, adenoma size, cavernous sinus invasion, or Ki-67 expression when compared to patients without residual adenomas following surgery. Among the 85 (65.4%) patients who had residual adenomas following primary surgery, 13 (15.3%) demonstrated an increase in size after a median follow-up of 44 (16-120) months. These patients tended to be older (P=0.058) and exhibited higher Ki-67 expression (P=0.05) compared to patients with stable residual adenomas.

Conclusion: Our results emphasize the importance of prolonged post-surgical monitoring for patients with NFPA to promptly detect potential tumour recurrence or an increase in residual tumour size, which are common occurrences in this patient group. Such a proactive approach can significantly impact treatment strategies and improve overall patient outcomes.

Keywords: non-functioning pituitary macroadenoma, surgery, residual adenoma, recurrence, long-term

Volume 99

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.